June 2026
You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedSM Biomed Sdn. Bhd. Market Share Analysis for June 2026
Established in 1991, SM Biomed Sdn. Bhd. is the first and largest API manufacturing company in Malaysia. For over 30 years, we are dedicated to create a profound impact in the health care industry. Today, we are the largest producer of Macrolide Antibiotics in Asia, serving over 500 customers across five continents with a comprehensive range of products to offer.
Industry: N/A
SM Biomed Sdn. Bhd. (including company regionals)
See more website traffic and engagement information- smbiomed.com
SM Biomed Sdn. Bhd. Revenue up to June 2026 is 2M - 5M
revenue generated by SM Biomed Sdn. Bhd. top domains
SM Biomed Sdn. Bhd. top domains revenue over 3 years
Revenue for SM Biomed Sdn. Bhd. top domains
Total visits to SM Biomed Sdn. Bhd.'s top domains
Understand SM Biomed Sdn. Bhd. market share and potential market reach.
Total visits last 3 months
Subsidiaries Breakdown
Avg. visit duration in SM Biomed Sdn. Bhd.'s top domains
Analyze SM Biomed Sdn. Bhd. engagement metrics.
Average visit duration last 3 months
Subsidiaries Breakdown
Avg. pageviews on SM Biomed Sdn. Bhd.'s top domains
See how SM Biomed Sdn. Bhd. keep users engaged, nurture their interest, and encourage them to take the next step.
Average page views last 3 months
Subsidiaries Breakdown
